Millions of Australians and people worldwide want to lose weight and be good-looking. They expend time and energy on losing extra pounds. Of course, we should not forget about money, especially when the treatment lasts many months or years.
One of the main functions of PBS is to provide Australians with modern medicines at an affordable price. We have good news for those who search: ” semaglutide australia pbs. Yes, this medicined is subsidised by PBS.
The PBS listed this new injectable drug in 2019. Thanks to this, consumers and taxpayers can save money by paying only part of the cost of Semaglutide. Without the federal government’s help, many people may not have been able to access the new treatment method.
Including Semaglutide in the PBS as a weight-loss medicine
I do not want to upset anyone, but we have some bad news.
Only the PBS subsidises Semaglutide as an anti-diabetic medication.
If you want to use Semaglutide for weight loss, you may have to pay the total cost of pre-filled pens, which can be very expensive.
Therapists consider the drug good for pharmacotherapy because it is safe and effective. However, the PBS list does not include this drug due to the high financial burden on public health.
Given the total number of people needing obesity treatment, substantial investments are expected. The federal government could spend $1 billion annually on the new obesity drug Wegovy (Semaglutide 2.4 mg) over the next six years.
It is worth noting that the state does not subsidise other popular medications for weight management, for example, Duromine, Saxenda or Contrave.
Conclusion
Some medications can cost a lot of money, especially newly developed ones. If you receive a prescription for Semaglutide to treat type 2 diabetes, you have every chance to pay only part of the cost of the medicine.
If you want to buy Semaglutide to treat obesity, you will have to pay the total price, as in the case of most other anti-obesity drugs.
